期刊文献+

不同海拔缺氧对大鼠心肌HIF-1α的影响研究 被引量:2

Effect of Different Geographic Altitude on Hypoxic Inducible Factor - 1α in Rats
原文传递
导出
摘要 目的:探讨不同海拔(2 500m以内)条件下对大鼠心肌的损伤作用及NO、MDA与HIF-1α的关系。方法:实验Wistar雄性大鼠18只,分为A组(海拔55m),B组(海拔1 520m)及C组(海拔2 260m)三组。在各海拔处标准饲养3日后处死取心脏,试剂盒测定低氧诱导因子(HIF-1α),丙二醛(MDA),一氧化氮(NO)。结果:C组与A组相比,HIF-1α、MDA明显增加(P<0.01),而NO明显降低(P<0.05);B组与A组相比,HIF-1α、MDA并无显著差异(P>0.05)。结论:不同海拔对大鼠心肌的影响不同,在2 260m海拔缺氧条件下,大鼠心肌确实能形成一定程度的氧化损伤,同时自由基的增加及NO的减少能在一定程度上促进HIF-1α的稳定性。 Objective:To investigate the influence role of different geographic altitude (within 2 500m) hypoxia on damage of cardiac myocyte in rats, and its relation to NO, MDA and HIF -1. Methods: 18 Wistar male rates were randomLy divided into 3 groups:control group A (55m), group B (1 520m) and group C (2 260m). All rates were killed after they were standard raised three days, and the activity of HIF - 1 and the concentration of MDA and NO of the hart were measured. Results:As compared with the control group A, the contents of HIF - 1 ot and MDA of heart tissue was significantly increased (P 〈0.01 and P 〈0.01) in group C. And the contents of NO of heart tissue were significantly decreased (P 〈 0.05 ) ; in group B, the contents of HIF - 1 α and MDA were not significantly deviation compared with control group A ( P 〉 0.05 ). Conclusions: There is a significant oxidative damage in the hypoxic cardiac myocyte at 2 260m altitudes. The increase of free radical and NO level could pro- mote the stability of HIF - 1α.
出处 《高原医学杂志》 CAS 2013年第1期5-8,共4页 Journal of High Altitude Medicine
基金 国家科技部重大资助项目(NO.2008ZXJ09014-010) 全军医药科研"十二五"重点项目(NO.BWS12J012)
关键词 低氧低气压 低氧诱导因子 丙二醛 一氧化氮 氧化损伤 High altitude HIF - 1α MDA Nitric oxide Oxidative damage
  • 相关文献

参考文献3

二级参考文献24

  • 1苏莉,朱旭阳,汪静宇,张纯兵,陈仁辉,李永宏.大鼠弥漫性脑损伤后脑组织HIF-1α的变化规律[J].法医学杂志,2005,21(4):244-245. 被引量:4
  • 2Ke Q,Costa M.Hypoxia-inducible factor-1 (HIF-1).Mol Pharmacol,2006,70:1469-1480.
  • 3Manolescu B,Oprea E,Busu C,et al.Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway.Biochimie,2009,91:1347-1358.
  • 4Wenger RH,Camenisch G,Stiehl DP,et al.HIF prolyl-4-hydroxylase interacting proteins:consequences for drug targeting.Curr Pharm Des,2009,15:3886-3894.
  • 5Hewitson KS,Liénard BM,McDonough MA,et al.Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates.J Biol Chem,2007,282:3293-3301.
  • 6Yan L,Colandrea VJ,Hale JJ.Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor:small molecule-based therapeutics for anemia.Expert Opin Ther Pat,2010,20:1219-1245.
  • 7Shi H.Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.Curr Med Chem,2009,16:4593-4600.
  • 8Cho H,Lee HY,Ahn DR,et al.Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.Mol Pharmacol,2008,74:70-81.
  • 9Schnitzer SE,Schmid T,Zhou J,et al.Inhibition of GSK3beta by indirubins restores HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia.FEBS Lett,2005,579:529-533.
  • 10Nagle DG,Zhou YD.Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1).Curr Pharm Des,2006,12:2673-2688.

共引文献7

同被引文献34

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部